StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Northland Capital Markets Downgrades Amarin Corporation (AMRN) to Market Perform
May 4, 2022 3:27 PM
Northland Capital Markets analyst Carl Byrnes downgraded Amarin Corporation (NASDAQ: AMRN) from Outperform to Market Perform with a price target ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Downgrades
Next Articles
Amarin Corporation (AMRN) PT Lowered to $9 at Cowen
May 4, 2022 12:55 PM
Form 8-K AMARIN CORP PLC\UK For: May 04
May 4, 2022 7:10 AM
Form 10-Q AMARIN CORP PLC\UK For: Mar 31
May 4, 2022 7:06 AM
Amarin Corp. (AMRN) Misses Q1 EPS by 6c
May 4, 2022 7:04 AM
Amarin Reports First Quarter 2022 Financial Results and Provides Business Update
May 4, 2022 7:00 AM
Form 4 AMARIN CORP PLC\UK For: May 02 Filed by: Marks Jason M.
May 3, 2022 8:04 PM
Amarin Corp. (AMRN) Reports New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction
May 3, 2022 8:12 AM
New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction (Heart Attack)
May 3, 2022 8:00 AM
New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction (Heart Attack)
May 3, 2022 8:00 AM
Form 10-K/A AMARIN CORP PLC\UK For: Dec 31
May 2, 2022 4:03 PM
